UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ to ____ Commission File Number: 000-26926 ScanSource, Inc. (Exact name of registrant as specified in its charter) South Carolina 57-0965380 (State or other juri ...

Exhibit 99.1 "We had a strong quarter, driven by a rebound in farming and steady results across our core operating segments," said Matthew Walker, president and CEO of Tejon Ranch Company. "Farming delivered an approximately $2 million positive variance from the prior year, helping year-to-date earnings recover. "As part of our comprehensive review of cost structure and capital allocation, we've taken decisive steps to reduce expenses, including a 20 percent reduction in our workforce. This difficult but ne ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-39327 SEADRILL LIMITED | (Exact name of Registrant as specified in its charter) | | | --- | --- | | Bermuda | 98-1834031 | | (St ...

Exhibit 99.1 MetaVia Reports Third Quarter 2025 Financial Results and Provides Corporate Update Dosed the First Patient in the 8-Week 48 mg MAD Cohort of its Phase 1 Clinical Trial to Further Explore Non-Titrated Maximum Tolerated Dose of DA- 1726 for the Treatment of Obesity; Top-Line Data Expected by Year-End 2025 $14.3 Million in Cash at End of Third Quarter is Expected to Fund the Company Into 2026 CAMBRIDGE, Mass., November 6, 2025 – MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company f ...

Exhibit 99.1 Tronox Reports Third Quarter 2025 Financial Results STAMFORD, Conn., November 5, 2025/PRNewswire/ — Tronox Holdings plc (NYSE:TROX) ("Tronox" or the "Company"), the world's leading integrated manufacturer of titanium dioxide ("TiO2") pigment, today reported its financial results for the quarter ending September 30, 2025, as follows: Third Quarter 2025 Financial Highlights: Updated Outlook: This outlook is based on Tronox's views on current global economic activity and is subject to changes and ...

Exhibit 99.1 CION also announced that, on November 3, 2025, its co-chief executive officers declared a fourth quarter 2025 base distribution of $0.36 per share, payable on December 15, 2025 to shareholders of record as of December 1, 2025. THIRD QUARTER AND OTHER HIGHLIGHTS DISTRIBUTIONS · Net investment income and earnings per share for the quarter ended September 30, 2025 were $0.74 per share and $0.69 per share, respectively; · Net asset value per share was $14.86 as of September 30, 2025 compared to $14 ...

EXHIBIT 99.1 Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos"), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the third quarter 2025. "Our Phase 2 B-SUPREME study of pevifoscorvir sodium (pevy) i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 22, 2025 Greystone Housing Impact Investors LP (Exact name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation) Delaware 001-41564 47-0810385 (Commission File Number) (IRS Employer Identification No.) 14301 FNB Parkway, Suite 211 Omaha, Nebraska 6815 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40568 CLEAR SECURE, INC. Delaware 86-2643981 (I.R.S. Employer Identification No.) (646) 723-1404 Registran ...

Revenue Performance - Revenue for Q3 2025 was $59.2 million, an increase of $7 million from Q2 2025, driven by orders from India Oil Marketing Companies and stronger ethanol prices[2]. - Total revenues for the first nine months of 2025 were $154.3 million, down from $220.6 million in the same period of 2024, primarily due to reductions in biodiesel contracts in India[8]. Profit and Loss - Gross loss for Q3 2025 was $58 thousand, compared to a gross profit of $3.9 million in Q3 2024[5]. - Net loss for Q3 2025 was $23.7 million, compared to a net loss of $17.9 million in Q3 2024[7]. - Operating loss for the first nine months of 2025 was $34.7 million, compared to $26.9 million for the same period in 2024[9]. - Net loss for the three months ended September 30, 2025, was $23,747 thousand, compared to a net loss of $17,935 thousand for the same period in 2024, representing an increase in loss of 32.5%[23]. - Adjusted EBITDA for the nine months ended September 30, 2025, was $(21,469) thousand, compared to $(9,197) thousand for the same period in 2024, indicating a worsening performance[23]. Cash and Assets - Cash increased to $5.6 million at the end of Q3 2025, up from $900 thousand at the end of 2024, supporting project execution in India[7]. - Total current assets decreased from $44,696 million in December 2024 to $15,554 million in September 2025, a decline of approximately 65.2%[21]. - Total current liabilities surged from $143,968 million in December 2024 to $343,365 million in September 2025, an increase of approximately 138%[21]. - The total stockholders' deficit increased from $(263,928) million in December 2024 to $(304,852) million in September 2025, reflecting a deterioration of approximately 15.5%[21]. Production and Sales - The Dairy Renewable Natural Gas segment produced 114,000 MMBtu from twelve operating digesters, generating $4 million in revenue[4]. - Ethanol gallons sold decreased from 15.5 million in Q3 2024 to 14.7 million in Q3 2025, a decline of 5.2%[25]. - Renewable Natural Gas MMBtu sold increased from 86.0 thousand in Q3 2024 to 114.0 thousand in Q3 2025, an increase of 32.6%[25]. - RINs sold increased from 935.3 thousand in Q3 2024 to 1,020.4 thousand in Q3 2025, an increase of 9.1%[25]. Costs and Pricing - Average sales price per gallon of ethanol increased from $2.12 in Q3 2024 to $2.13 in Q3 2025, a slight increase of 0.5%[25]. - The average delivered cost per bushel of corn decreased from $6.07 in Q3 2024 to $5.95 in Q3 2025, a reduction of 1.97%[25]. Future Plans - Aemetis plans to sell $20 million of Section 45Z and Section 48 tax credits following the completion of a multi-dairy biogas digester in September 2025[2]. - Aemetis is developing a sustainable aviation fuel and renewable diesel fuel biorefinery in California to produce low carbon intensity renewable jet and diesel fuel[12]. Interest Expense - Interest expense for the first nine months of 2025 was $39 million, up from $34 million in the same period of 2024[10].